Bruker Corporation
NASDAQ Global SelectTotal Valuation
Bruker Corporation carries a market capitalization of 8.22B, placing it among publicly traded companies globally. Its enterprise value stands at 7.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.22B |
| Enterprise Value | 7.08B |
Share Statistics
Bruker Corporation currently has 152.22M shares outstanding.
| Shares Outstanding | 152.22M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Bruker Corporation trades at a trailing price-to-earnings ratio of 78.45. The price-to-sales ratio is 1.59, and the price-to-book ratio stands at 2.32.
| PE Ratio | 78.45 |
| PS Ratio | 1.59 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 199.51 |
| P/FCF Ratio | 23.97 |
| P/OCF Ratio | 39.11 |
Enterprise Valuation
On an enterprise value basis, Bruker Corporation trades at an EV/EBITDA multiple of 16.17 and an EV/FCF ratio of 32.81. The EV/Sales ratio of 2.05 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 33.79 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.05 |
| EV / EBITDA | 16.17 |
| EV / EBIT | 33.79 |
| EV / FCF | 32.81 |
Financial Position
Bruker Corporation maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.78, indicating elevated leverage, while an interest coverage ratio of 7.37 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.55 |
| Quick Ratio | 0.65 |
| Debt / Equity | 66.78 |
| Debt / EBITDA | 3.82 |
| Interest Coverage | 7.37 |
Financial Efficiency
Bruker Corporation posts a return on equity of -1.52 and a return on invested capital of -1.18.
| Return on Equity (ROE) | -1.52 |
| Return on Assets (ROA) | -0.19 |
| Return on Invested Capital (ROIC) | -1.18 |
| Return on Capital Employed (ROCE) | -0.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.69 |
Taxes
Over the trailing twelve months, Bruker Corporation has paid 23.10M in income taxes, reflecting an effective tax rate of 122.87.
| Income Tax | 23.10M |
| Effective Tax Rate | 122.87 |
Stock Price Statistics
Bruker Corporation's stock has gained approximately 35.98162% over the past 52 weeks. The 50-day moving average sits at 43.69, while the 200-day moving average is 41.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | 35.98162% |
| 50-Day Moving Average | 43.69 |
| 200-Day Moving Average | 41.20 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Bruker Corporation generated 3.46B in revenue and converted that into -11.60M in net income, yielding earnings per share of -0.06. EBITDA reached 437.70M, while operating income came in at 209.50M.
| Revenue | 3.46B |
| Gross Profit | 1.57B |
| Operating Income | 209.50M |
| Pretax Income | 18.80M |
| Net Income | -11.60M |
| EBITDA | 437.70M |
| EBIT | 209.50M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
Bruker Corporation holds 133.40M in cash and equivalents against 1.67B in total debt, resulting in a net debt position of 1.54B. Total book value stands at 2.36B, with working capital of 748.50M providing operational flexibility.
| Cash & Cash Equivalents | 133.40M |
| Total Debt | 1.67B |
| Net Debt | 1.54B |
| Equity (Book Value) | 2.36B |
| Book Value Per Share | 15.54 |
| Working Capital | 748.50M |
Cash Flow
Bruker Corporation produced 140.30M in operating cash flow over the past twelve months. After subtracting -89.00M in capital expenditures, free cash flow totaled 51.30M - equivalent to 0.34 per share.
| Operating Cash Flow | 140.30M |
| Capital Expenditures | -89.00M |
| Free Cash Flow | 51.30M |
| FCF Per Share | 0.34 |
Margins
Bruker Corporation operates with a gross margin of 45.29, reflecting its pricing power and cost economics. The operating margin of 6.06 and net profit margin of -0.34 provide insight into operational efficiency.
| Gross Margin | 45.29 |
| Operating Margin | 6.06 |
| Pretax Margin | 0.54 |
| Profit Margin | -0.34 |
| EBITDA Margin | 12.66 |
Dividends & Yields
The company's payout ratio of -59.37 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.29 |
| Dividend Yield | N/A |
| Payout Ratio | -59.37 |
| Shareholder Yield | 0.34 |
| FCF Yield | 4.17 |
Scores
Bruker Corporation posts an Altman Z-Score of 3.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.19 |